References
- 1. Shaw JE, Sicree RA, Zimmet PZ. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 87(1), 4-14.
- 2. American diabetes association. (2008). Diagnosis and Classification of Diabetes Mellitus. Diabetes care 31(1), 55-60.
- 3. Ceriello A. (2000). Oxidative stress and glycemic regulation. Metabolism. 49(2, Suppl 1):27-29.
- 4. Baynes JW, Thorpe SR. (1999). Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48:1-9.
- 5. Maritim AC, Sanders RA, and Watkins JB III. (2003). Diabetes, Oxidative Stress, and Antioxidants: A Review. J biochem molecular toxicology. 17(1), 24-38.
- 6. Vincent AM, Russell JW, Low P, Feldman EL. (2004). Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 25(4), 612-28.
- 7. Geerlings S, Hoepelman A. (1999). Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 26(3-4), 259-65.
- 8. Abbas A, Lichtman A, Pillai S Cellular and molecular immunology, 8edition
- 9. Xiu F, Stanojcic M, Diao L, Jeschke M. (2014). Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol. 2014:486403. doi: 10.1155/2014/486403.
- 10. Berrou J, Fougeray S, Venot M, Chardiny V, Gautier JF, Dulphy N, Toubert A, Peraldi MN. (2013). Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes Plos One. 8(4):e62418. doi: 10.1371/journal.pone.0062418.
- 11. Qin H, Lee IF, Panagiotopoulos C, Wang X, Chu AD, Utz PJ, Priatel JJ, Tan R. (2011). Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling. Diabetes. 60(3), 857-66.
- 12. Slauenwhite D, Johnston B. (2015). Regulation of NKT cell localization in homeostasis and infection. Frontiers in Immunology 6:255. doi: 10.3389/fimmu.2015.00255.
- 13. Kumar V, Delovitch TL. (2014). Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology. 142(3), 321-36.
- 14. Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, Smyth MJ, Godfrey DI. (2007). IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol. 178(5), 2827-34.
- 15. Marrero I, Ware R, Kumar V. (2015). Type II NKT cells in inflammation, autoimmunity, microbial immunity, and cancer. Front Immunol. 17;6:316. doi: 10.3389/ fimmu.2015.00316.
- 16. Godfrey DI, Stankovic S, Baxter AG. (2010). Raising the NKT cell family. Nat Immunol. 11(3), 197-206.
- 17. McCord JM, Fridovich I (1969) The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem. 244(22), 6056-6063.
- 18. Beutler E (1982) Catalase. In: Beutler E (ed) Red cell metabolism, a manual of biochemical methods. Grune and Stratton, New York, pp 105-106
- 19. Misra HP, Fridovich I. (1972). The role of superoxideanion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247, 3170-3175.
- 20. Jovanovic I, Radosavljevic G, Milovanovic M, Martinova K, Pejnovic N, Arsenijevic N, Lukic M. (2012). Suppressed innate immune response against mammary carcinoma in balb/c mice. Ser J Exp Clin Res. 13 (2), 55-61.
- 21. Choi SW, Benzie IF, Ma SW, Strain JJ, Hannigan BM. (2008). Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med. 44(7), 1217-31.
- 22. Jakus V. (2000). The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy. 101(10), 541-51.
- 23. Verhasselt V, Goldman M, Willems F. (1998). Oxidative stress up-regulates IL-8 and TNF-alpha synthesis by human dendritic cells. Eur J Immunol. 28(11), 3886-90.
- 24. Matés JM. (2000). Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 153(1-3), 83-104.
- 25. Hwang I, Lee J, Huh JY, Park J, Lee HB, Ho YS, Ha H. (2012). Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes. 61(3), 728-38.
- 26. Fujita H, Fujishima H, Chida S, Takahashi K, Qi Z, Kanetsuna Y, Breyer MD, Harris RC, Yamada Y, Takahashi T. (2009). Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol. 20(6), 1303-13.
- 27. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. (2002). Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23(5), 599-622.
- 28. Robertson FC, Berzofsky JA, Terabe M. (2014). NKT cell networks in the regulation of tumor immunity. Front Immunol. 5:543. doi: 10.3389/fimmu.2014.00543.
- 29. Girardi E, Maricic I, Wang J, Mac TT, Iyer P, Kumar V, Zajonc DM. (2012). Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Nat Immunol. 13(9), 851-6.
- 30. Terabe M, Berzofsky JA. (2007). NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis. Trends Immunol. 28(11), 491-6.
- 31. Sakuishi K, Oki S, Araki M, Porcelli SA, Miyake S, Yamamura T. (2007). Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol. 179(6), 3452-62.
- 32. Constantinides M, Bendelac A. (2013). Trancriptional regulation of the NKT cell lineage. Curr Opin Immunol. 25(2), 161-167.
- 33. Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, McKenzie BS, Berzins SP, Smyth MJ, Godfrey DI. (2008). Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A. 105(32), 11287-92.
- 34. Hadad U, Thauland T, Butte M, Porgador A, Krams S. (2014). NKp46 modulates NK immune synapse function (INC6P.346). The Journal of Immunology. 192 (1 Supplement) 121.13
- 35. Yu J, Mitsui T, Wei M, Mao H, Butchar JP, Shah MV, Zhang J, Mishra A, Alvarez-Breckenridge C, Liu X, Liu S, Yokohama A, Trotta R, Marcucci G Jr, Benson DM, Loughran TP Jr, Tridandapani S, Caligiuri MA. (2011). NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. J Clin Invest. 121(4):1456-70.
- 36. Jovanovic I, Radosavljevic G, Mitrovic M, Lisnic Juranic V, McKenzie ANJ, Arsenijevic N, Jonjic S, Lukic ML. (2011). ST2 Deletion Enhances Innate and Acquired Immunity to Murine Mammary Carcinoma. Eur J Immunol. 41: 1902-1912.
- 37. Shimizu K, Sato Y, Shinga J, Watanabe T, Endo T, Asakura M, Yamasaki S, Kawahara K, Kinjo Y, Kitamura H, Watarai H, Ishii Y, Tsuji M, Taniguchi M, Ohara O, Fujii S. (2014). KLRG+ invariant natural killer T cells are long-lived effectors. Proc Natl Acad Sci U S A. 111(34), 12474-9.
- 38. Terabe M, Park JM, Berzofsky JA. (2004). Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother. 53(2), 79-85.
- 39. Oki S, Chiba A, Yamamura T, and Miyake S. (2004). The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest. 113(11), 1631-1640.
- 40. Usui T, Nishikomori R, Kitani A, Strober W. (2003). GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity._ 18(3), 415-28.
- 41. Onishi R, Gaffen S. (2010). Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 129(3), 311-321.
- 42. Gaffen S. (2008). An overview of IL-17 function and signaling. Cytokine. 43(3), 402-407.
- 43. Terabe M, Berzofsky JA. (2008). The role of NKT cells in tumor immunity. Adv Cancer Res. 101:277-348.
- 44. Tamada K, Harada M, Abe K, Li T, Tada H, Onoe Y, Nomoto K. (1997). Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes. J Immunol. 158(10), 4846-54.
- 45. Terabe M, Matsui S, Park JM, Mamura M, Noben- Trauth N, Donaldson DD, Chen W,Wahl SM,Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA. (2003).Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocytemediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med. 198(11), 1741-52.
- 46. Pang Y, Gara SK, Achyut BR, Li Z, Yan HH, Day CP, Weiss JM, Trinchieri G, Morris JC, Yang L. (2013). TGF-β signaling in myeloid cells is required for tumor metastasis. Cancer Discov. 3(8), 936-51.